IL198290A0 - Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies - Google Patents
Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergiesInfo
- Publication number
- IL198290A0 IL198290A0 IL198290A IL19829009A IL198290A0 IL 198290 A0 IL198290 A0 IL 198290A0 IL 198290 A IL198290 A IL 198290A IL 19829009 A IL19829009 A IL 19829009A IL 198290 A0 IL198290 A0 IL 198290A0
- Authority
- IL
- Israel
- Prior art keywords
- allergies
- medicament
- prevention
- preparation
- treatment
- Prior art date
Links
- 206010020751 Hypersensitivity Diseases 0.000 title 1
- 108010078233 Thymalfasin Proteins 0.000 title 1
- 102400000800 Thymosin alpha-1 Human genes 0.000 title 1
- 230000007815 allergy Effects 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- NZVYCXVTEHPMHE-ZSUJOUNUSA-N thymalfasin Chemical compound CC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O NZVYCXVTEHPMHE-ZSUJOUNUSA-N 0.000 title 1
- 229960004231 thymalfasin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000583A ITRM20060583A1 (it) | 2006-10-27 | 2006-10-27 | Uso della timosina alfa 1 per la preparazione di un medicamento per la prevenzione e la cura delle allergie |
| PCT/IT2007/000676 WO2008050362A2 (en) | 2006-10-27 | 2007-09-27 | Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL198290A0 true IL198290A0 (en) | 2011-08-01 |
Family
ID=39322638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL198290A IL198290A0 (en) | 2006-10-27 | 2009-04-22 | Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090270594A1 (https=) |
| EP (1) | EP2083847A2 (https=) |
| JP (1) | JP2010507649A (https=) |
| KR (1) | KR20090092267A (https=) |
| CN (1) | CN101626778A (https=) |
| AU (1) | AU2007310415A1 (https=) |
| BR (1) | BRPI0718019A2 (https=) |
| CA (1) | CA2666562A1 (https=) |
| EA (1) | EA200900603A1 (https=) |
| IL (1) | IL198290A0 (https=) |
| IT (1) | ITRM20060583A1 (https=) |
| MX (1) | MX2009004237A (https=) |
| WO (1) | WO2008050362A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6984522B2 (en) | 2000-08-03 | 2006-01-10 | Regents Of The University Of Michigan | Isolation and use of solid tumor stem cells |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4079127A (en) * | 1976-10-28 | 1978-03-14 | Board Of Regents Of The University Of Texas | Thymosin alpha 1 |
| AR020102A1 (es) * | 1998-07-30 | 2002-04-10 | Ucb Sa | Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento |
| US20060121029A1 (en) * | 2002-08-30 | 2006-06-08 | Hiroshi Shiku | Method and composition for regulating the activity of regulatory t cells |
| DK1613340T3 (da) * | 2003-03-28 | 2010-08-30 | Sciclone Pharmaceuticals Inc | Behandling af aspergillus-infektioner med thymosin alfa 1 |
-
2006
- 2006-10-27 IT IT000583A patent/ITRM20060583A1/it unknown
-
2007
- 2007-09-27 MX MX2009004237A patent/MX2009004237A/es not_active Application Discontinuation
- 2007-09-27 CA CA002666562A patent/CA2666562A1/en not_active Abandoned
- 2007-09-27 WO PCT/IT2007/000676 patent/WO2008050362A2/en not_active Ceased
- 2007-09-27 EP EP07827727A patent/EP2083847A2/en not_active Withdrawn
- 2007-09-27 EA EA200900603A patent/EA200900603A1/ru unknown
- 2007-09-27 CN CN200780039959A patent/CN101626778A/zh active Pending
- 2007-09-27 KR KR1020097008098A patent/KR20090092267A/ko not_active Withdrawn
- 2007-09-27 AU AU2007310415A patent/AU2007310415A1/en not_active Abandoned
- 2007-09-27 BR BRPI0718019-5A patent/BRPI0718019A2/pt not_active IP Right Cessation
- 2007-09-27 US US12/447,156 patent/US20090270594A1/en not_active Abandoned
- 2007-09-27 JP JP2009534060A patent/JP2010507649A/ja active Pending
-
2009
- 2009-04-22 IL IL198290A patent/IL198290A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2666562A1 (en) | 2008-05-02 |
| WO2008050362A3 (en) | 2008-07-10 |
| EP2083847A2 (en) | 2009-08-05 |
| ITRM20060583A1 (it) | 2008-04-28 |
| EA200900603A1 (ru) | 2009-10-30 |
| AU2007310415A1 (en) | 2008-05-02 |
| MX2009004237A (es) | 2009-07-07 |
| BRPI0718019A2 (pt) | 2013-11-19 |
| JP2010507649A (ja) | 2010-03-11 |
| CN101626778A (zh) | 2010-01-13 |
| US20090270594A1 (en) | 2009-10-29 |
| KR20090092267A (ko) | 2009-08-31 |
| WO2008050362A2 (en) | 2008-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL177914A0 (en) | Use of indazolecarboxamide derivatives for the preparation of a medicament that is intended for the treatment and prevention of paludism | |
| IL249165A0 (en) | Use of an antigen-mhc complex to prepare drugs for the prevention and treatment of autoimmune conditions | |
| IL200278A (en) | Use of aclidinium for the manufacture of a drug for use in the treatment or prevention of respiratory illness and pharmacist's preparation for the treatment or prevention of respiratory illness | |
| IL207439B (en) | Use of an antagonistic antibody against calcitonin gene-related peptide (cgrp) for the preparation of a drug for the prevention and/or treatment of joint pain | |
| ZA200700771B (en) | Vaccine for prevention and treatment of HIV-infection | |
| EP1940361A4 (en) | PHARMACEUTICAL DOSAGE FORMS HAVING CONTROLLED AND / OR IMMEDIATE RELEASE PROPERTIES | |
| IL210589A (en) | C2386RV Protein Tuberculosis Kvfb Protein Use for the Treatment or Prevention of TB | |
| IL195947A (en) | Manicured cyclic compounds and pharmaceutical preparations containing them for use @ for prevention @ and treatment @ for diabetes | |
| IL199045A0 (en) | Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases | |
| ZA200800206B (en) | "One-way valve for medical infusion lines and the like" | |
| IL189162A0 (en) | Use of hydroxybenzoic acid ester and analogues for the manufacture of a medicament for the prevention and treatment of virus infection | |
| GB2443336B (en) | Spiruchostatin analogues and their medicinal use | |
| IL193094A (en) | Appalidine and other drugs used in the manufacture of a cancer treatment drug when the combination of the two gives a synergistic result | |
| IL206080A0 (en) | Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases | |
| IL184037A0 (en) | Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis | |
| IL203986A0 (en) | Cdh3 peptide and medicinal agent comprising the same | |
| TWI369210B (en) | Use of lgg in the manufacture of a medicament for the prevention or treatment of respiratory allergies | |
| IL195955A0 (en) | Use of thymosin alpha 1 for preparing a medicament for the treatment of stage iv malignant melanoma | |
| EP2010215A4 (en) | METHOD AND COMPOSITIONS FOR TREATING MORBUS CROHN | |
| EP2005964A4 (en) | MEDICAMENT FOR TREATING HYPERPHOSPHATEEMIA AND PREPARATION METHOD THEREOF | |
| IL177609A (en) | Use of gobacoline or its analogue to produce a drug to treat liver carcinoma | |
| IL198291A0 (en) | Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases | |
| IL198290A0 (en) | Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies | |
| EP2065049A4 (en) | USE OF SOLIDAGO VIRGAUREA IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT AND PREVENTION OF A VIRUS | |
| ZA200900257B (en) | Use of thymosin Alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma |